Assessment of efficacy of a potential probiotic strain and its antiuremic andantioxidative activities

e-SPEN Journal

Volumn 8, Issue 4, 2013, Pages

  Mandal, Arpita ^a   Mandal, Shreya ^a   Roy, Suchismita ^a   Patra, Arpita ^a   Pradhan, Shrabani ^a   Das, Koushik ^a   Paul, Tanmay ^b   Mondal, Keshab Ch ^b   Nandi, Dilip Kumar ^a  

^a Raja Narendra Lal Khan Women's College   (India)

^b VIDYASAGAR UNIVERSITY   (India)

Author keywords

Antioxidant; Antiuremic; Probiotic; Sporosarcina pasteurii (MTCC 1761)

Indexed keywords

ANTIOXIDANT; BILE SALT; CREATININE; MILK PROTEIN; PARACETAMOL; PROBIOTIC AGENT; STARCH; UREA; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD COMPONENT; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFICACY; HYDROPHOBICITY; IN VITRO STUDY; KIDNEY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; MALE; NONHUMAN; PH; PROTEIN DEGRADATION; RAT; SPOROSARCINA PASTEURII; UREA BLOOD LEVEL; UREMIA;

EID: 84880700812     PISSN: None     EISSN: 22128263     Source Type: Journal    
DOI: 10.1016/j.clnme.2013.05.001     Document Type: Article

References (35)

1. Jain A.K., McLeod I., Huo C. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int 2009, 76(3):318-323.
2. Ghosh J., Das J., Manna P., Sil P.C. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-_B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol 2009, 240:73-87.
3. Sparks R.E. Review of gastrointestinal perfusion in the treatment of uremia. Clin Nephrol 1979, 11:81-85.
4. ®, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996, 74:349-355.
5. Prakash S., Chang T.M.S. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat Med 1996, 2:883-887.
6. Takayama F., Kentaro T., Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 2003, 41:S142-S145.
7. Ranganathan N., Patel B.G., Ranganathan P. Invitro and invivo assessment ofintraintestinal bacteriotherapy in chronic kidney disease. ASAIO J 2006, 52:70-79.
8. Mandal A., Roy S., Das K., Mondal K., Nandi D. Invivo assessment of bacteriotherapy on acetaminophen induced uremic rats. JNephrol 2013, 26(1):228-236.
9. Erkkilä S., Petäjä E. Screening of commercial meat starter cultures at low pH andin the presence of bile salts for potential probiotic use. Meat Sci 2000, 55:297-300.
10. Charteris W.P., Kelly P.M., Morelli L., Collin J.K. Development and application of an invitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus & Bifidobacterium species in the upper human gastrointestinal tract. JAppl Microbiol 1998, 84:759-768.
11. Thapa N., Pal J., Tamang J.P. Microbial diversity in ngari, hentak and tungtap, fermented fish products of North-East, India. World J Microbiol Biotechnol 2004, 20:599-607.
12. Rammelsberg M., Radler F. Antibacterial polypeptides of Lactobacillus species. JAppl Bacteriol 1990, 69:177-184.
13. Musikasang H., Tani A., H-kittikun A., Maneerat S. Probiotic potential of lactic acid bacteria isolated from chicken gastrointestinal digestive tract. World J Microbiol Biotechnol 2009, 25:1337-1345.
14. Natarajan K.R. Kinetic study of the enzyme urease from Dolichos biXorus. JChem Educ 1995, 72:556-557.
15. Wanasundrara U., Amarowicz R., Shahidi F. Isolation and identification of an antioxidative component in canola meal. JAgric Food Chem 1994, 420:1285-1290.
16. Shimada K., Fujikawa K., Yahara K., Nakamura T. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. JAgric Food Chem 1992, 40:945-948.
17. Huebner J., Wang Y., Krueger W.A., Madoff L.C., Martirosian G., Boisot S., et al. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun 1999, 67:1213-1219.
18. Olert E.D., Cross B.M., McWilliam A.A. Guide to care and use of experimental animals 1993, vol. 1:1-90. Canadian Council on Animal Care, Ottawa. 2nd ed.
19. Burtis C.A., Ashwood E.R. Tietz textbook of clinical chemistry 1999, WB Saunders Company, Philadelphia. 3rd ed.
20. Sabbagh M., Rick W., Schneide R.S. Akinetic method for the direct determination of creatinine in serum with 3,5-dinitrobenzoic acid without deproteinization. JClin Chem Clin Biochem 1988, 26:15-24.
21. Fossati P., Prencipe L., Berti G. Use of 3,5-dichloro-2-hydroxy-benzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymetic assay of uric acid in serum and urine. Clin Chem 1980, 26:227-231.
22. Lin K.T., Xue J.Y., Sun F.F., Wong P.Y.K. Reactive oxygen species participate in peroxinitrile induced apoptosis in HL 60 cells. Biochem Biophys Res Commun 1997, 230:115-119.
23. Das J., Ghosh J., Manna P., Sil P.C. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology 2010, 269:24-34.
24. Van K.E., Zijlstra W.G. Standardization of hemoglobinometry. II. The hemiglobincyanide method. Clin Chim Acta 1961, 6:538-545.
25. Gilliland S.E., Rich C.N. Stability during frozen and subsequent refrigerated storage of Lactobacillus acidophilus grown at different pH. JDairy Sci 1990, 73:1187-1192.
26. Gilbert P., Evans D.J., Evans E., Duguid I.G., Brown M.R.W. Surface characteristics and adhesion of Escherichia coli and Staphylococcus epidermis. JAppl Bacteriol 1991, 71(1):72-77.
27. Gomes D.A., Souza A.M.L., Lopes R.V., Nunes A.C., Nicoli R.J. Comparison of antagonistic ability against enteropathogens by G+ and G- anaerobic dominant components of human fecal microbiota. Folia Microbiol 2006, 51:141-145.
28. Duangchitchareon Y. Selection of probiotic lactic acid bacteria from pickles andbiologically fermented plant products 2006, Dissertation, Chang Mai University.
29. Larson A.D., Kallio R.E. Purification and properties of bacterial urease. JBacteriol 1954, 68:67-73.
30. Lin M.Y., Chang F.Y. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 2000, 45:1617-1622.
31. Schnellman R.G. Toxic responses of the kidney. Casarett and Doull's toxicology 2001, 491-514. The Basic Science of Poisons, McGraw-Hill Medical Publishing Division, New York.
32. Emeigh Hart S.G.E., Wyand D.S., Khairallah E.A., Cohen S.D. Arole for the glutathione conjugate and renal cytochrome P450 in acetaminophen (APAP) induced nephrotoxicity in the CD-1 mouse. Toxicol 1990, 11:5-6.
33. Verpooten G.A., Tulkens P.M., Bennett W.M. Aminoglycosides and vancomycin. Clinical nephrotoxicants, renal injury from drugs and chemicals 1998, 105-120. Kluwer, Netherland. M.E. De Broe, G.A. Porter, A.M. Bennett, G.A. Verpooten (Eds.).
34. Abdel-Zaher O.A., Abdel-Rahman M.M., Hafez M.M. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen induced hepatic and renal damage. Toxicology 2007, 243:124-134.
35. Guyton A.C. Red blood cells, anemia, and polycythemia. Textbook of medical physiology 1991, W B Sunders Co, Philadelphia. 8th ed.